A. O'Shea

Safety of high dose trivalent inactivated influenza vaccine in pediatric patients with acute lymphoblastic leukemia

J. McCullers, N. Halasa, H. Frangoul, 2013, Pediatric blood & cancer.

Poor immune responses to a birth dose of diphtheria, tetanus, and acellular pertussis vaccine.

B. LaFleur, K. Edwards, N. Halasa, 2008, The Journal of pediatrics.

The absence of enhanced disease with wild type respiratory syncytial virus infection occurring after receipt of live, attenuated, respiratory syncytial virus vaccines.

R. Karron, B. Murphy, W. Gruber, 2007, Vaccine.

Randomized, double‐blind comparison of standard‐dose vs. high‐dose trivalent inactivated influenza vaccine in pediatric solid organ transplant patients

C. Fonnesbeck, J. McCullers, N. Halasa, 2015, Pediatric transplantation.

The interferon antagonist NS2 protein of respiratory syncytial virus is an important virulence determinant for humans.

S. Madhi, R. Karron, B. Murphy, 2006, The Journal of infectious diseases.